Every one of those 1 sits in a single category, pharma. Animal Birth Control Clinic is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Boehringer-Ingelheim, all published on August 12, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Boehringer-Ingelheim
Every one of those 1 sits in a single category, pharma. Animal Birth Control Clinic is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Boehringer-Ingelheim, all published on August 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 11 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Boehringer-Ingelheim. Shared-story counts are live from our verified record — not editorial picks.
Boehringer-Ingelheim donates 32,000 doses of its parasiticide NexGard to Waco, Texas, in a $600,000 public-private initiative to prevent New World Screwworm infestation. The proactive distribution model and off-label use of afoxolaner highlight pharmaceutical strategies in emerging veterinary biosecurity threats.